The SYNCHRONIZE-1 trial evaluated survodutides safety and efficacy in adults with overweight or obesity, excluding those with type 2 diabetes
How to integrate multiple clinical and operational systems without breaking compliance, How to customize workflows when off-the-shelf tools arent enough, How to design user experiences that support patient adherence,and how to build a platform flexible enough to keep up with regulation, reimbursement, and clinical change
Glucagon-like peptide-1 receptor agonists and microvascular outcomes in type 2 diabetes: A systematic review and meta-analysis
GLP-1 Multidistrict Litigation Status 2025 As of 2025, hundreds of Ozempic lawsuits filed against Novo Nordisk have been consolidated into multidistrict litigation (MDL) in the Eastern District of Pennsylvania
Messaging implying the compounded product is clinically proven to achieve the same results as an FDAapproved product, or otherwise performs the same